NCT00863655 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 485
- group Id
- BG001
- value
- 239
- group Id
- BG002
- value
- 724
- units
- Participants
- groups
- description
- Everolimus 10 mg daily in combination with exemestane 25 mg daily
- id
- BG000
- title
- Everolimus + Exemestane
- description
- Placebo of everolimus in combination with exemestane 25 mg daily
- id
- BG001
- title
- Placebo + Exemestane
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.31
- value
- 62.5
- group Id
- BG001
- spread
- 9.75
- value
- 61.2
- group Id
- BG002
- spread
- 10.14
- value
- 62.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 290
- group Id
- BG001
- value
- 159
- group Id
- BG002
- value
- 449
- title
- < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 195
- group Id
- BG001
- value
- 80
- group Id
- BG002
- value
- 275
- title
- >= 65 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 485
- group Id
- BG001
- value
- 239
- group Id
- BG002
- value
- 724
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 485
- group Id
- BG001
- value
- 239
- group Id
- BG002
- value
- 724
- units
- Participants
- groups
- description
- Everolimus 10 mg daily in combination with exemestane 25 mg daily
- id
- BG000
- title
- Everolimus + Exemestane
- description
- Placebo of everolimus in combination with exemestane 25 mg daily
- id
- BG001
- title
- Placebo + Exemestane
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.31
- value
- 62.5
- group Id
- BG001
- spread
- 9.75
- value
- 61.2
- group Id
- BG002
- spread
- 10.14
- value
- 62.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 290
- group Id
- BG001
- value
- 159
- group Id
- BG002
- value
- 449
- title
- < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 195
- group Id
- BG001
- value
- 80
- group Id
- BG002
- value
- 275
- title
- >= 65 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 485
- group Id
- BG001
- value
- 239
- group Id
- BG002
- value
- 724
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle